Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [¹⁸F]FDG PET/CT in Metastatic Melanomas and Lung Cancer

par Egesta Lopci
Publié 2021

How I faced my prostate cancer: a molecular biologist’s perspective

par Monica Zuradelli, Massimo Lazzeri, Egesta Lopci, Paolo Andrea Zucali, Luca Balzarini, Giorgio Guazzoni, Piergiuseppe Colombo, Marta Scorsetti, Ciro Franzese, Rosanna Asselta, Giulia Soldà, Stefano Duga
Publié 2021

Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography

par Daniela E. Oprea-Lager, Daniela E. Oprea-Lager, Matthijs C.F. Cysouw, Ronald Boellaard, Christophe M. Deroose, Christophe M. Deroose, Christophe M. Deroose, Lioe-Fee de Geus-Oei, Lioe-Fee de Geus-Oei, Egesta Lopci, Luc Bidaut, Luc Bidaut, Ken Herrmann, Laure S. Fournier, Laure S. Fournier, Laure S. Fournier, Tobias Bäuerle, Nandita M. deSouza, Nandita M. deSouza, Nandita M. deSouza, Frederic E. Lecouvet, Frederic E. Lecouvet
Publié 2021